Health Care & Life Sciences » Biotechnology | Actinogen Medical Ltd.

Actinogen Medical Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,127.70
9,805.60
4,778.00
3,989.40
10,003.80
Total Accounts Receivable
10.80
181.50
2,928.60
1,341.80
3,485.00
Other Current Assets
15.20
34.00
37.70
33.00
47.40
Total Current Assets
1,153.60
10,021.10
7,744.20
5,364.30
13,536.20
Net Property, Plant & Equipment
106.60
6.80
8.40
2.30
-
Total Investments and Advances
1.50
-
-
-
-
Intangible Assets
-
5,551.40
5,197.00
4,843.50
4,490.00
Total Assets
1,261.70
15,579.20
12,949.60
10,210.00
18,026.20
Accounts Payable
8.90
192.30
689.80
649.10
507.40
Other Current Liabilities
41.00
30.40
134.40
195.10
260.90
Total Current Liabilities
49.90
222.60
824.20
844.30
768.30
Total Liabilities
49.90
222.60
824.20
844.30
768.30
Common Equity (Total)
1,211.80
15,356.60
12,125.40
9,365.80
17,257.90
Total Shareholders' Equity
1,211.80
15,356.60
12,125.40
9,365.80
17,257.90
Total Equity
1,211.80
15,356.60
12,125.40
9,365.80
17,257.90
Liabilities & Shareholders' Equity
1,261.70
15,579.20
12,949.60
10,210.00
18,026.20

About Actinogen Medical

View Profile
Address
109 Pitt Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.actinogen.com.au
Updated 07/08/2019
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders. The company was founded by David Keast on March 23, 1999 and is headquartered in West Perth, Australia. .